TDG is a novel tumor suppressor of liver malignancies
- PMID: 32944627
- PMCID: PMC7469547
- DOI: 10.1080/23723556.2020.1768819
TDG is a novel tumor suppressor of liver malignancies
Abstract
In a recent publication, we demonstrated that conditional deletion of the gene encoding thymine DNA glycosylase (TDG) leads to a late onset of hepatocellular carcinoma (HCC). TDG loss causes disruption in active DNA demethylation in the liver and dysregulation of the farnesoid X receptor and small heterodimer partner (FXR-SHP) regulatory cascade. This leads to a loss of bile acid and glucose homeostasis, which predisposes mice to HCC.
Keywords: FXR; SHP; Thymine DNA Glycosylase; active DNA demethylation; bile acid; glucose intolerance; hepatocellular carcinoma; liver cancer; ten eleven translocation.
© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.
Figures
References
-
- Xu J, Cortellino S, Tricarico R, Chang W-C, Scher G, Devarajan K, Slifker M, Moore R, Bassi MR, Caretti E. Thymine DNA Glycosylase (TDG) is involved in the pathogenesis of intestinal tumors with reduced APC expression. Oncotarget. 2017;8(52):89988–89997. doi:10.18632/oncotarget.21219. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources